No connection

Search Results

GOSS vs QTI

GOSS
Gossamer Bio, Inc.
BEARISH
Price
$0.37
Market Cap
$87.2M
Sector
Healthcare
AI Confidence
95%
QTI
QT Imaging Holdings, Inc.
BEARISH
Price
$6.93
Market Cap
$83.5M
Sector
Healthcare
AI Confidence
90%

Valuation

P/E Ratio
GOSS
--
QTI
--
Forward P/E
GOSS
-2.23
QTI
--
P/B Ratio
GOSS
-0.71
QTI
12.79
P/S Ratio
GOSS
1.8
QTI
4.41
EV/EBITDA
GOSS
-0.94
QTI
-18.18

Profitability

Gross Margin
GOSS
100.0%
QTI
45.36%
Operating Margin
GOSS
-333.65%
QTI
-8.46%
Profit Margin
GOSS
0.0%
QTI
-111.4%
ROE
GOSS
--
QTI
--
ROA
GOSS
-41.86%
QTI
-19.05%

Growth

Revenue Growth
GOSS
47.1%
QTI
877.2%
Earnings Growth
GOSS
--
QTI
--

Financial Health

Debt/Equity
GOSS
--
QTI
0.81
Current Ratio
GOSS
2.64
QTI
2.81
Quick Ratio
GOSS
2.36
QTI
2.07

Dividends

Dividend Yield
GOSS
--
QTI
--
Payout Ratio
GOSS
0.0%
QTI
0.0%

AI Verdict

GOSS BEARISH

GOSS exhibits critical financial distress, highlighted by a Piotroski F-Score of 0/9, indicating the weakest possible fundamental health. The company suffers from negative equity (Price/Book of -0.71) and an unsustainable operating margin of -333.65%. Despite positive revenue growth, the stock is in a catastrophic technical death spiral, losing over 85% of its value in the last six months. The massive discrepancy between the current price ($0.37) and the analyst target ($3.69) suggests a significant lag in analyst updates or extreme speculative optimism not supported by the deterministic data.

Strengths
Strong YoY revenue growth of 47.10%
Healthy short-term liquidity with a Current Ratio of 2.64
Quick Ratio of 2.36 suggests immediate obligations can be met
Risks
Negative Book Value (P/B -0.71) indicating liabilities exceed assets
Piotroski F-Score of 0/9 signals severe fundamental deterioration
Extreme price decay with a 5-year decline of 95.6%
QTI BEARISH

The company exhibits critical financial weakness with a Piotroski F-Score of 1/9, indicating severe fundamental distress. Despite an extraordinary YoY revenue growth of 877.20%, the company remains deeply unprofitable with a profit margin of -111.40% and a history of massive earnings misses. Technical trends are overwhelmingly bearish, characterized by a 78.7% price collapse over the last six months. While short-term liquidity is stable, the combination of poor health scores and negative earnings progression suggests a high risk of further devaluation.

Strengths
Explosive YoY revenue growth of 877.20%
Strong gross margin of 45.36% indicating product value
Healthy short-term liquidity with a Current Ratio of 2.81
Risks
Critical fundamental health as evidenced by Piotroski F-Score of 1/9
Severe net losses with a profit margin of -111.40%
Catastrophic price performance (-95.3% over 5 years)

Compare Another Pair

GOSS vs QTI: Head-to-Head Comparison

This page compares Gossamer Bio, Inc. (GOSS) and QT Imaging Holdings, Inc. (QTI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile